Orchid Pharma shareholders and shareholding pattern
NSE: ORCHPHARMABSE: 524372Pharmaceuticals & BiotechnologySmall Cap
Orchid Pharma Limited · Formerly Orchid Chemicals & Pharmaceuticals · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 1993 on BSE, Jul 2010 on NSE
Last close ₹835.35up ₹17.00 (2.08%)BSE ₹835.05
Share price at the NSE close on 27 Oct 2026. Previous close ₹818.35.
27 Oct: open ₹818.35, high ₹841.90, low ₹818.35
52-week range of traded prices to 27 Oct 2026
₹480.00Low, 30 Mar 2026₹1,143.50High, 22 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹5,003 Cr919th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 0.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.19
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 54,56657.3% delivered
Orchid Pharma's shareholding pattern for Sep 2026, filed on 17 Oct 2026, with every filing from Dec 2016: who owns its shares by group, its promoters by name and its public holders of 1% or more.
Who owns Orchid Pharma, filing by filing
Per cent of all the company's shares, counting those held against depositary receipts traded abroad where a filing has them.
Sep 2026 filing
- Promoters74.45%
- Foreign institutions0.93%
- Indian institutions17.44%
- Individuals and others7.18%
- Depositary receiptsNone
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Foreign institutions
- Indian institutions
- Individuals and others
- Depositary receipts
| Per cent | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020Filing | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27.32% | 25.72% | 25.71% | 25.71% | 25.72% | 25.72% | 25.71% | 25.71% | 25.71% | 25.71% | 25.71% | 25.71% | 25.71% | 98.00% | 25.71% | 25.71% | 98.04% | 98.04% | 89.96% | 89.96% | 89.96% | 89.96% | 89.96% | 89.96% | 89.96% | 89.96% | 72.40% | 72.40% | 69.84% | 69.84% | 69.84% | 69.84% | 69.84% | 69.84% | 69.84% | 69.84% | 69.84% | 69.84% | 69.84% | 74.45% | |
| Indian promoters | 27.32% | 25.72% | 25.71% | 25.71% | 25.72% | 25.72% | 25.71% | 25.71% | 25.71% | 25.71% | 25.71% | 25.71% | 25.71% | – | 25.71% | 25.71% | 98.04% | 98.04% | 89.96% | 89.96% | 89.96% | 89.96% | 89.96% | 89.96% | 89.96% | 89.96% | 72.40% | 72.40% | 69.84% | 69.84% | 69.84% | 69.84% | 69.84% | 69.84% | 69.84% | 69.84% | 69.84% | 69.84% | 69.84% | 74.45% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. Public in the glossary | 69.05% | 70.66% | 70.66% | 70.66% | 70.66% | 70.65% | 70.66% | 70.66% | 70.66% | 70.66% | 70.66% | 70.66% | 70.66% | 1.96% | 70.66% | 70.66% | 1.92% | 1.92% | 10.00% | 10.00% | 10.00% | 10.00% | 10.04% | 10.04% | 10.04% | 10.04% | 27.60% | 27.60% | 30.16% | 30.16% | 30.16% | 30.16% | 30.16% | 30.16% | 30.16% | 30.16% | 30.16% | 30.16% | 30.16% | 25.55% |
| Depositary receipts | 3.63% | 3.63% | 3.63% | 3.63% | 3.63% | 3.63% | 3.63% | 3.63% | 3.63% | 3.63% | 3.63% | 3.63% | 3.63% | 0.04% | 3.63% | 3.63% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Promoter shares pledgedShare of the promoters' own shares | 84.70% | 83.75% | 83.77% | 83.77% | 83.75% | 99.91% | 99.96% | 99.96% | 99.96% | 99.96% | 99.96% | 99.96% | 99.96% | 0.00% | 99.96% | 99.96% | 0.04% | 0.04% | 32.68% | 32.68% | 32.68% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Shares in issue | 8,89,64,327 | 8,89,64,327 | 8,89,64,327 | 8,89,64,327 | 8,89,64,327 | 8,89,64,327 | 8,89,64,327 | 8,89,64,327 | 8,89,64,327 | 8,89,64,327 | 8,89,64,327 | 8,89,64,327 | 8,89,64,327 | 4,08,16,400 | 8,89,64,327 | 8,89,64,327 | 4,08,16,400 | 4,08,16,400 | 4,08,16,400 | 4,08,16,400 | 4,08,16,400 | 4,08,16,400 | 4,08,16,400 | 4,08,16,390 | 4,08,16,400 | 4,08,16,400 | 5,07,19,105 | 5,07,19,105 | 5,07,19,105 | 5,07,19,105 | 5,07,19,105 | 5,07,19,105 | 5,07,19,105 | 5,07,19,105 | 5,07,19,105 | 5,07,19,105 | 5,07,19,105 | 5,07,19,105 | 5,07,19,105 | 5,98,85,200 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. Shares locked in in the glossary | – | 1,000 | 1,000 | 1,000 | 37,03,450 | 37,03,450 | 37,03,450 | 37,02,450 | 37,02,450 | – | – | – | – | 4,03,90,891 | – | – | 4,03,90,891 | 4,04,08,236 | 2,51,28,099 | 2,51,28,099 | 2,51,28,099 | 1,02,703 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – | – | – | – | – | – |
| Promoters' shares locked in | – | 1,000 | 1,000 | 1,000 | 37,03,450 | 37,03,450 | 37,03,450 | 37,02,450 | 37,02,450 | – | – | – | – | 4,00,00,072 | – | – | 4,00,00,072 | 4,00,00,072 | 2,47,19,935 | 2,47,19,935 | 2,47,19,935 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – | – | – | – | – | – |
| Shares underlying depositary receipts | 32,26,688 | 32,26,688 | 32,26,688 | 32,26,688 | 32,26,688 | 32,26,688 | 32,26,688 | 32,26,688 | 32,26,688 | 32,26,688 | 32,26,688 | 32,26,688 | 32,26,688 | 14,803 | 32,26,688 | 32,26,688 | 14,803 | 14,803 | 14,803 | 14,803 | 14,803 | 14,803 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – | – | – | – | – | – |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. Pledged is the share of the promoters' own shares given to lenders as security. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Orchid Pharma promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Triveni Trust, 32.62%.Promoter buying and selling
| Holder | ||
|---|---|---|
| Triveni TrustIndian companies, trusts and others | 32.62% | 1,95,36,706 |
| MANISH DHANUKAIndividuals and Hindu undivided families | 10.94% | 65,52,539 |
| Pushpa Dhanuka TrustIndian companies, trusts and others | 9.68% | 57,95,034 |
| MAMTA DHANUKAIndividuals and Hindu undivided families | 5.20% | 31,16,960 |
| ARJUN DHANUKAIndividuals and Hindu undivided families | 4.82% | 28,85,925 |
| UMA DHANUKAIndividuals and Hindu undivided families | 3.15% | 18,83,700 |
| PUSHPA DHANUKAIndividuals and Hindu undivided families | 3.09% | 18,51,822 |
| MEGHA CHIRIPALIndividuals and Hindu undivided families | 1.08% | 6,44,000 |
| VARSHA GOELIndividuals and Hindu undivided families | 1.08% | 6,44,000 |
| MANAS DHANUKAIndividuals and Hindu undivided families | 0.58% | 3,44,540 |
| MRIDUL DHANUKA HUFIndividuals and Hindu undivided families | 0.54% | 3,22,000 |
| HARSH DHANUKA HUFIndividuals and Hindu undivided families | 0.54% | 3,22,000 |
No promoter shares are reported as pledged.
Largest public holders of Orchid Pharma, filing by filing
Per cent, on the same shares as the split above.Mutual funds holding Orchid Pharma
| Holder | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020Filing | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CARNELIAN STRUCTURAL SHIFT FUNDAlternative investment funds | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.22% | 1.22% | 1.22% | 1.22% | – | – | – | – | – | – | – | – | – | – |
| Massachusetts Institute of TechnologyForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.64% | 2.91% | – | – | – | – | – | – | – | – | – | – | – |
| Max Life Insurance Company Limited A/c - ULIF00225/06/04LIFEBALANC104 - Balanced FundInsurance companies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.44% | – | – | – | – | – | – | – | – | – | – | – |
| Societe GeneraleForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.57% | – | – | – | – | – | – | – | – | – | – | – | – |
| 238 PLAN ASSOCIATES LLCForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.22% | – | – | – | – | – | – | – | – | – | – | – | – |
| AURIGIN MASTER FUND LIMITEDInstitutions Foreign Portfolio Investor | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.78% | 1.78% | 1.77% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| LIFE INSURANCE CORPORATION OF INDIAInsurance companies | – | 2.59% | 2.59% | 2.59% | 2.59% | 2.59% | 2.59% | 2.59% | 2.59% | 2.59% | 2.59% | 2.59% | 2.59% | – | 2.59% | 2.59% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| SERUM INSTITUTE OF INDIA PVT LTDOther non-institutions | 6.41% | 6.41% | 6.41% | 5.21% | 2.73% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| ADURJEE & BROS PRIVATE LIMITEDOther non-institutions | 1.95% | 1.97% | 1.97% | 1.45% | 1.45% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| FORTUNE INTERCONTINENTAL PVT.LTDOther non-institutions | 1.36% | 1.59% | 1.59% | 1.27% | 1.27% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Cobra India (Mauritius) LimitedInstitutions Foreign Portfolio Investor | – | 1.07% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. Mutual funds are left out here: each fund's holding is on the Mutual funds tab, from its own portfolio. A dash is a filing that did not name the holder, which includes holding under one per cent.